Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial

Lancet

Volumn 357, Issue 9256, 2001, Pages 577-581

  Smilde, T J ^a   Van Wissen, S ^b   Wollersheim, H ^a   Trip, M D ^b   Kastelein, J J P ^b   Stalenhoef, A F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; STATIN;

ADULT; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

EID: 0035941786     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04053-8     Document Type: Article

References (29)

1. Variability in B-mode ultrasound measurements in the atherosclerosis risk communities (ARIC) study
2. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular high risk factors in the general population of a Japanese city: The Suita study
3. Carotid and femoral wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia
4. Cardiovascular determination of carotid artery disease: The Rotterdam elderly study
5. Arterial wall thickness is associated with prevalent cardiovascular disease in middle aged adults: The Atheorsclerosis Risk in Communities (ARIC) study
6. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerotic Risk in Communities (ARIC) study, 1987-1993
7. The role of carotid arterial intima media thickness in predicting clinical coronary events
8. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomised, controlled clinical trial
9. Effects of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolaemic patients with coronary artery disease
10. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events
11. Carotid intima media thickness and plaque in patients with familial hypercholesterolemia mutations and control subjects
12. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens
13. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: Factors limiting achievement of lipid goals
14. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
15. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
16. Reduction of LDL cholesterol by 25-60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor
17. Rationale, design and baseline characteristics of a clinical trial comparing the effect of robust vs. conventional cholesterol lowering and intima media thickness in patients with familial hypercholesterolemia: The atorvastatin vs simvastatin on atherosclerosis progression (ASAP) study
18. Immunoephelometric assay of human apolipoprotein A1
19. Influence of apolipoprotein (a) phenotype on lipoprotein (a) quantification: Evaluation of three methods
20. Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging
21. The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolemia
22. Task force report. Prevention of coronary heart disease in clinical practice: Recommendations of the school joint task force of European and other societies on coronary prevention
23. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects
24. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenus-vein coronary-artery bypass graft
25. Kuopio Atherosclerosis Prevention Study (KAPS): A population-based primary preventive trial of the effect of LDL lowering on atherosclerosis progression in carotid and femoral arteries
26. Carotid intima media thickness measurements: What defines an abnormality? A systematic review
27. Effect of greater LDL-C reductions on prognosis: The Incremental Decrease in Endpoints through Aggressive Lipid Lowering (IDEAL) trial
28. Cholesterol lowering in atherosclerosis
29. "The lower the better" in hypercholesterolemia therapy: A reliable clinical guideline?